Drugs Made In America Acquisition (DMII) Common Equity (2024 - 2025)
Drugs Made In America Acquisition (DMII) reported Common Equity of -$17.8 million for Q4 2025, down 15128.73% year-over-year from N/an in Q4 2024, and down 2.86% quarter-over-quarter from -$17.3 million in Q3 2025.
Drugs Made In America Acquisition (DMII) Common Equity (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has 2 years of Common Equity data on file, last reported at -$17.8 million in Q4 2025.
- Common Equity for Q4 2025 came in at -$17.8 million, down 15128.73% year-over-year; the trailing twelve-month figure through Dec 2025 was -$17.8 million (down 15128.73% YoY), and the FY2025 annual result was -$17.8 million, down 15128.73% from the prior year.
- Common Equity slipped to -$17.8 million in Q4 2025 per DMII's latest filing, from -$17.3 million in the prior quarter.
- Over five years, Common Equity peaked at -$116719.0 in Q4 2024 and troughed at -$17.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | -16.30 Mn |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | -14.48 Mn |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | -12.19 Mn |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | -11.23 Mn |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | -13.79 Mn |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | -13.71 Mn |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | -29.19 Mn |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | -8.10 Mn |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | -30.99 Mn |
| 10 | Drugs Made In America Acquisition | 129.34 Mn | 129.34 Mn | - | -17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17.77 Mn |
| Sep 30, 2025 | -17.28 Mn |
| Dec 31, 2024 | -116,719.00 |